• 1
    Berg, D.E., Gilman, R.H., Lelwala-Guruge, J., Srivastava, K., Valdez, Y., Watanabe, J., et al (1997) Helicobacter pylori populations in Peruvian patients. Clin Infect Dis 25: 9961002.
  • 2
    Bryant, C. & Deluca, M. (1991) Purification and characterization of an oxygen-insensitive NAD (P)H nitroreductase from Enterobacter cloacae. J Biol Chem 266: 41264130.
  • 3
    Byrant, C., Hubbard, L., McElroy, W.D. (1991) Cloning, nucleotide sequence, and expression of the nitroreductase gene from Enterobacter cloacae. J Biol Chem 266: 41264130.
  • 4
    Bukanov, N.O. & Berg, D.E. (1994) Ordered cosmid library and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638. Mol Microbiol 11: 509523.
  • 5
    Chang, K.C., Ho, S.W., Yang, J.C., Wang, J.T. (1997) Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori. Biochem Biophys Res Commun 236: 785788.
  • 6
    Chiba, N., Rao, B.V., Rademaker, J.W., Hunt, R.H. (1992) Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 87: 17161726.
  • 7
    Correa, P. (1996) Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev 5: 477481.
  • Devereux, J., Haberli, P., and Smithies, O. (1984)
    A comprehensive set of sequence analysis programs for the Vax. Nucleic Acids Res 12: 387389.
  • 9
    Dunn, B.E., Cohen, H., Blaser, M.J. (1997) Helicobacter pylori. Clin Microbiol Rev 10: 720741.
  • 10
    Edwards, D.I. (1993) Nitroimidazole drugs — action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother 31: 920.
  • 11
    Ellis, H.R. & Poole, L.B. (1997) Roles for the two cysteine residues of AhpC in catalysis of peroxide reduction by alkyl hydroperoxide reductase from Salmonella typhimurium. Biochemistry 36: 1334913356.
  • 12
    Glupczynski, Y. & Burette, A. (1990) Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 85: 15451551.
  • 13
    Graham, D.Y., Lew, G.M., Klein, P.D., Alpert, L.C., Genta, R.M. (1992) Factors affecting the eradication of Helicobacter pylori infection with triple therapy. Gastroenterology 192: 16367.
  • 14
    Grunberg, E. & Titsworth, E. (1973) Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings. Annu Rev Microbiol 27: 317347.
  • 15
    Hof, H. & Sticht-Groh, V. (1984) Antibacterial effects of niridazole: Its effect on microaerophilic Campylobacter. Infection 12: 3639.
  • 16
    Hoffman, P.S., Butler, C.A., Quinn, F.D. (1989) Cloning and temperature-dependent expression in Escherichia coli of a Legionella pneumophila gene coding for a genus-common 60-kilodalton antigen. Infect Immun 57: 17311739.
  • 17
    Hoffman, P.S., Goodwin, A., Johnsen, J., Magee, K., Veldhuyzen van Zanten, S.J.O. (1996) Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori : repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bacteriol 178: 48224829.
  • 18
    Inouye, S. (1994) NAD (P)H-flavin oxidoreductase from the bioluminescent bacterium, Vibrio fischeri ATCC 7744 is a flavoprotein. FEBS Lett 347: 163168.
  • 19
    Kedderis, G.L., Argenbright, L.S., Miwa, G.T. (1988) Mechanism of reductive activation of a 5-nitroimidazole by flavoproteins: model studies with dithionite. Arch Biochem Biophys 262: 4048.
  • 20
    Lacey, S.L., Moss, S.F., Taylor, G.W. (1993) Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori. J Antimicrob Chemother 32: 393400.
  • 21
    Lariviere, L.A., Gaudreau, C.L., Turgeon, F.F. (1986) Susceptibility of clinical isolates of Campylobacter jejuni to 25 antimicrobial agents. J Antimicrob Chemother 18: 681685.
  • 22
    Levy, S.B. (1992) The Antibiotic Paradox: How Miracle Drugs are Destroying the Miracle. New York: Plenum Press.
  • 23
    Lindmark, D.G. & Muller, M. (1976) Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother 10: 476482.
  • 24
    Lockerby, D.L., Rabin, H.R., Laishley, E.J. (1985) Role of the phosphoroclastic reaction of Clostridium pasteurianum in the reduction of metronidazole. Antimicrob Agents Chemother 27: 863867.
  • 25
    McNulty, C.A., Dent, J., Wise, R. (1985) Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother 28: 837838.
  • 26
    Malfertheiner, P., Megraud, F., O'Morain, C. (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 41: 813.
  • 27
    Moreno, S.N.J., Mason, R.P., Muniz, R.P.A., Cruz, R.S., Docampo, R. (1983). Generation of free radicals from metronidazole and other nitroimidazoles by Tritrichomonas foetus. J Biol Chem 258: 40514054.
  • 28
    Narikawa, S. (1986) Distribution of metronidazole susceptibility factors in obligate anaerobes. J Antimicrob Chemother 18: 565574.
  • 29
    Pavicic, M.J., Van Winkelhoff, A.J., Pavivic-Temming, Y.A., De Graaff, J. (1995) Metronidazole susceptibility factors in Actinobacillus actinomycetemcomitans. J Antimicrob Chemother 35: 263269.
  • 30
    Rasmussen, B.A., Bush, K., Tally, F.P. (1997) Antimicrobial resistance in anaerobes. Clin Infect Dis 24: S110S120.
  • 31
    Sambrook, J., Fritsch, E.F., Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
  • 32
    Smith, M.A. & Edwards, D.I. (1995) Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs. J Antimicrob Chemother 35: 751764.
  • 33
    Smith, M.A. & Edwards, D.I. (1997) Oxygen scavenging NADH oxidase and metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 39: 347353.
  • 34
    Taylor, D.N. & Parsonnet, J. (1995) Epidemiology and natural history of H. pylori infections. In Infections of the gastrointestinal tract. Blaser, M.J., Smith, P.F., Ravdin, J., Greenberg, H., and Guerrant R.L. (eds). New York: Raven Press, pp. 551564.
  • 35
    Thompson, S.A. & Blaser, M.J. (1995) Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH. Infect Immun 63: 21852193.
  • 36
    Tomb, J.F., White, O., Kerlavage, A.R., Clayton, R.A., Sutton, G.G., Fleischmann, R.D., et al (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539547.
  • 37
    Veldhuyzen van Zanten, S.J.O., Sherman, P.M., Hunt, R.H. (1997) Helicobacter pylori : new developments and treatments. Can Med Assoc J 156: 15651574.
  • 38
    Volkert, M.R. (1988) Adaptive response of Escherichia coli to alkylation damage. Environ Mol Mutagen 11: 241255.
  • 39
    Volkert, M.R. (1989) Altered induction of the adaptive response to alkylation damage in Escherichia coli recF mutants. J Bacteriol 171: 99103.
  • 40
    Wang, Y. & Taylor, D.E. (1990) Chloramphenicol resistance in Campylobacter coli : nucleotide sequence, expression, and cloning vector construction. Gene 94: 2328.
  • 41
    Wang, Y., Roos, P., Taylor, D.E. (1993) Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J Gen Microbiol 139: 24852493.
  • 42
    Watanabe, M., Ishidate, Jr, M., Nohmi, T. (1989) A sensitive method for the detection of mutagenic nitroarenes: construction of nitroreductase-overproducing derivatives of Salmonella typhimurium strains TA98 and TA100. Mutat Res 216: 211220.
  • 43
    Watanabe, M., Ishidate, Jr, M., Nohmi, T. (1990) Nucleotide sequence of Salmonella typhimurium nitroreductase gene. Nucleic Acids Res 18: 1059.
  • 44
    Yamada, M., Espinosa-Aguirre, J.J., Watanabe, M., Matsui, K., Sofuni, T., Nohmi, T. (1997) Targeted disruption of the gene encoding the classical nitroreductase enzyme in Salmonella typhimurium Ames test strains TA1535 and TA1538. Mutat Res 375: 917.
  • 45
    Zenno, S., Saigo, K., Kanoh, H., Inouye, S. (1994) Identification of the gene encoding the major NAD(P)H-flavin oxidoreductase of the bioluminescent bacterium Vibrio fischeri ATCC 7744. J Bacteriol 176: 35363543.
  • 46
    Zenno, S., Koike, H., Tanokura, M., Saigo, K. (1996a) Gene cloning, purification, and characterization of NfsB, a minor oxygen-insensitive nitroreductase from Escherichia coli, similar in biochemical properties to Frase I, the major flavin reductase in Vibrio fischeri. J Biochem 120: 736744.
  • 47
    Zenno, S., Koike, H., Kumar, A.N., Jayaraman, R., Tanokura, M., Saigo, K. (1996b) Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. J Bacteriol 178: 45084514.